Should rituximab be used to treat antineutrophil cytoplasmic antibody associated vasculitis?

類似資料

• Remission in antineutrophil cytoplasmic antibody-associated systemic vasculitis.
  著者:: Mukhtyar, C, 等
  出版事項: (2006)
• Cardiovascular outcomes in antineutrophil cytoplasm antibody associated vasculitis (AAV)
  著者:: Mukhtyar, C, 等
  出版事項: (2008)
• Is rituximab “The Wonder Drug” for antineutrophil cytoplasmic antibodies-associated vasculitis?
  著者:: Saket Jha, 等
  出版事項: (2019-01-01)
• Severe Infections following Rituximab Treatment in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
  著者:: Zhi-Ying Li, 等
  出版事項: (2020-08-01)
• A Case of Postcoronavirus Disease 2019 Antineutrophil Cytoplasmic Antibody-associated Vasculitis Successfully Treated with Rituximab
  著者:: Mahmoud M. Mohamed, 等
  出版事項: (2023-07-01)